Digestive Health Virtual CME Series 2022: Third Thursdays Trust your Gut

Thursday, January 20, 2022, 5:00 PM - 6:00 PM, Online

Provide world class digestive health educational programming, professional development and networking opportunities for physicians, clinicians and specialty providers. This series will focus on several key digestive health topics including Abnormal Liver Function Tests, Gall Stones & Biliary Colic, Intestinal Stomas, Esophageal Swallow Disorders, Eating Disorders, Post Bariatric Complications, Constipation, Anorectal Disorders, Diarrhea, Abdominal Pain, and Celiac Disease/Gluten Sensitivity. The overall goal of this unique conference series is to provide up-to-date evidence-based education in the diagnosis and management of gastrointestinal and liver diseases.

 

Register for the January webinar.

FEB 17
Gallstones & Biliary Colic - A Case Presentation

MAR 17
Updates On Colon Cancer Screening

APR 21
Celiac Disease & Gluten Sensitivity

MAY 19
Esophageal Swallowing Disorders - A Case Presentation

JUN 16
Recognizing Eating Disorders

JULY 21
Management Of Patients After Bariatric Surgery - A Case Presentation

AUG 18
Constipation

SEP 15
Anorectal Disorders II

OCT 20
Practical Approach to Diarrhea - A Case Presentation

NOV 17
Abdominal Pain: When to Image & Refer - A Case Presentation

DEC 15
Intestinal Stomas: A Primer for PCPs

1. Describe how to implement evidence-based medicine in the diagnosis and management of gastrointestinal and liver diseases;
2. State the role of emerging technologies for medical and surgical management of gastrointestinal diseases;
3. Evaluate different views in controversial areas of the surgical and medical management of gastrointestinal and liver diseases;
4. Outline up to date guidelines for the monitoring and management of gastrointestinal diseases

Registration fees:

• Physicians - Complimentary
• Nurses/PAs/Allied Health Professionals - Complimentary
• Non-Yale Residents/Fellows/Students† - Complimentary
• Yale Residents/Fellows/Students† - Complimentary

†A letter of verification from department head must accompany registration. Letter should be sent separately to Yale CME at the address below. You may also e-mail a pdf copy of your verification letter to [email protected].  

Center for Continuing Medical Education
Yale School of Medicine
333 Cedar Street
PO Box 208052
New Haven, CT 06520-8052

*PLEASE NOTE: Online registration will close at 1 pm the day of the program and the Zoom webinar link will be forwarded to registrants at that time. 

The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The Yale School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs.  All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

Mitigation of Relevant Financial Relationships

Yale Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.